| 1 |
Shariati S, Lou J, Milton L, Behroozian T, Zhang L, Lam E, Wong G, Karam I, Chow E. Impact of adjuvant radiotherapy on patient-reported shortness of breath in patients with breast cancer using the ESAS. J Med Imaging Radiat Sci 2023:S1939-8654(23)00008-5. [PMID: 36804014 DOI: 10.1016/j.jmir.2023.01.008] [Reference Citation Analysis]
|
| 2 |
Eghbali M, Haber ZM, Srinivasa RN, Padia SA. Complications of 90Y Radioembolization Treatment for Liver Tumors. Digestive Disease Interventions 2023. [DOI: 10.1055/s-0043-1760730] [Reference Citation Analysis]
|
| 3 |
Niu L, Chu X, Yang X, Zhao H, Chen L, Deng F, Liang Z, Jing D, Zhou R. The radiotherapy planning CT-based multi-omics for predicting the radiation pneumonitis in lung cancer patients: A multi-center study.. [DOI: 10.21203/rs.3.rs-2462632/v1] [Reference Citation Analysis]
|
| 4 |
Bai J, Yu Q, Wang Y, Xu L, Wang J, Zhai J, Bao Q, Guo W, Wu C, Zhang K, Shou W, Zhu G. Iodine-125 brachytherapy suppresses tumor growth and alters bone metabolism in a H1299 xenograft mouse model. Med Oncol 2023;40:72. [PMID: 36607460 DOI: 10.1007/s12032-022-01937-z] [Reference Citation Analysis]
|
| 5 |
Thakur P, Olson JD, Dugan GO, Bourland JD, Kock ND, Cline JM. Quantitative Assessment and Comparative Analysis of Longitudinal Lung CT Scans of Chest-Irradiated Nonhuman Primates. Radiat Res 2023;199:39-47. [PMID: 36394559 DOI: 10.1667/RADE-21-00225.1] [Reference Citation Analysis]
|
| 6 |
Zeng W, Song Y, Wang R, He R, Wang T. Neutrophil elastase: From mechanisms to therapeutic potential. Journal of Pharmaceutical Analysis 2023. [DOI: 10.1016/j.jpha.2022.12.003] [Reference Citation Analysis]
|
| 7 |
Makkar P, Geyer A. Lung cancer. Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease 2023. [DOI: 10.1016/b978-0-323-68135-3.00048-9] [Reference Citation Analysis]
|
| 8 |
Hossain CM, Maitra S, Lyle N, Gera M, Paul S, Dutta D. IMMUNOTHERAPY AS NOVEL TREATMENT OF LUNG CANCER: A SYSTEMATIC REVIEW. Asian J Pharm Clin Res 2022. [DOI: 10.22159/ajpcr.2022.v15i12.46133] [Reference Citation Analysis]
|
| 9 |
Wang Q, Stone K, Kern JA, Slatore CG, Swanson S, Blackstock W Jr, Khan RS, Smith CB, Veluswamy RR, Chidel M, Wisnivesky JP. Adverse Events Following Limited Resection versus Stereotactic Body Radiation Therapy for Early Stage Lung Cancer. Ann Am Thorac Soc 2022;19:2053-61. [PMID: 35816617 DOI: 10.1513/AnnalsATS.202203-275OC] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Garassino MC, Mazieres J, Reck M, Chouaid C, Bischoff H, Reinmuth N, Cove-Smith L, Mansy T, Cortinovis D, Migliorino MR, Delmonte A, Sánchez JG, Chara Velarde LE, Bernabe R, Paz-Ares L, Perez ID, Trunova N, Foroutanpour K, Faivre-Finn C. Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial. J Thorac Oncol 2022;17:1415-27. [PMID: 35961520 DOI: 10.1016/j.jtho.2022.07.1148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 11 |
Bai J, Yu Q, Wang Y, Xu L, Wang J, Zhai J, Bao Q, Guo W, Wu C, Zhang K, Shou W, Zhu G. Iodine-125 brachytherapy suppresses tumor growth and alters bone metabolism in a H1299 xenograft mouse model.. [DOI: 10.21203/rs.3.rs-2288958/v1] [Reference Citation Analysis]
|
| 12 |
Hsu CX, Lin KH, Shueng PW, Wu YW, Tsai WT, Chang CH, Tien HJ, Wang SY, Wu TH, Mok GSP. Integrating (18) F-FDG PET/CT with lung dose-volume for assessing lung inflammatory changes after arc-based radiotherapy for esophageal cancer: A pilot study. Thorac Cancer 2022;13:3114-23. [PMID: 36163634 DOI: 10.1111/1759-7714.14661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Karampitsakos T, Sampsonas F, Spagnolo P, Tzouvelekis A. Pulmonary effects of cancer treatments. Lung Diseases and Cancer 2022. [DOI: 10.1183/2312508x.10020421] [Reference Citation Analysis]
|
| 14 |
Andarini S, Hilmi Taufikulhakim F, Maryam S, Zaini J. Pulmonary infections in cancer patients. Lung Diseases and Cancer 2022. [DOI: 10.1183/2312508x.10019822] [Reference Citation Analysis]
|
| 15 |
Käsmann L, Taugner J, Nieto A, Belka C, Eze C, Manapov F. Radiation-Induced Lung Injury: Prevention, Diagnostics and Therapy in the Era of the COVID-19 Pandemic. JCM 2022;11:5713. [DOI: 10.3390/jcm11195713] [Reference Citation Analysis]
|
| 16 |
Thomas HMT, Hippe DS, Forouzannezhad P, Sasidharan BK, Kinahan PE, Miyaoka RS, Vesselle HJ, Rengan R, Zeng J, Bowen SR. Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics? Discov Oncol 2022;13:85. [PMID: 36048266 DOI: 10.1007/s12672-022-00548-4] [Reference Citation Analysis]
|
| 17 |
Gram VR, Gram D, Persson GF, Suppli MH, Barrett S. Reduction of oesophageal toxicity with VMAT dose-sparing radiotherapy in thoracic metastatic spinal cord compression: A feasibility study. Technical Innovations & Patient Support in Radiation Oncology 2022;23:8-14. [DOI: 10.1016/j.tipsro.2022.07.001] [Reference Citation Analysis]
|
| 18 |
Yen A, Westover KD. Case Report: Resolution of radiation pneumonitis with androgens and growth hormone. Front Oncol 2022;12:948463. [DOI: 10.3389/fonc.2022.948463] [Reference Citation Analysis]
|
| 19 |
Zhang A, Yang F, Gao L, Shi X, Yang J. Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer. Cancer Manag Res 2022;14:2469-83. [PMID: 35991677 DOI: 10.2147/CMAR.S374648] [Reference Citation Analysis]
|
| 20 |
Nie Y, Yao G, Li L, Feng A, Zhang W, Xu X, Li Q, Yang Z. Effects of Radiotherapy on Survival of Esophageal Cancer Patients Receiving Immunotherapy: Propensity Score Analysis and Nomogram Construction. CMAR 2022;Volume 14:2357-71. [DOI: 10.2147/cmar.s375821] [Reference Citation Analysis]
|
| 21 |
Berg J, Halvorsen AR, Bengtson M, Lindberg M, Halvorsen B, Aukrust P, Helland Å, Ueland T. Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer. Front Immunol 2022;13:875152. [DOI: 10.3389/fimmu.2022.875152] [Reference Citation Analysis]
|
| 22 |
Arifin AJ, Palma DA. The changing landscape of pneumonitis in non-small cell lung cancer. Lung Cancer 2022;171:1-2. [PMID: 35849898 DOI: 10.1016/j.lungcan.2022.07.008] [Reference Citation Analysis]
|
| 23 |
Kilicoglu O, Kara U, Ozgenc E, Gundogdu E. Pre-clinic study of radiopharmaceutical for Covid-19 inactivation: Dose distribution with Monte Carlo Simulation. Appl Radiat Isot 2022;188:110364. [PMID: 35839712 DOI: 10.1016/j.apradiso.2022.110364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 24 |
Chen T, Zhuang B, Huang Y, Liu Y, Yuan B, Wang W, Yuan T, Du L, Jin Y. Inhaled curcumin mesoporous polydopamine nanoparticles against radiation pneumonitis. Acta Pharm Sin B 2022;12:2522-32. [PMID: 35646537 DOI: 10.1016/j.apsb.2021.10.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Jost T, Schultz AK, Frey B, Vu J, Fietkau R, Distel LV, Hecht M. Influence of alectinib and crizotinib on ionizing radiation - in vitro analysis of ALK/ROS1-wildtype lung tissue cells. Neoplasia 2022;27:100780. [PMID: 35278911 DOI: 10.1016/j.neo.2022.100780] [Reference Citation Analysis]
|
| 26 |
Hsu CX, Lin KH, Wang SY, Tsai WT, Chang CH, Tien HJ, Shueng PW, Wu TH, Mok GSP. Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer. Sci Rep 2022;12:2513. [PMID: 35169144 DOI: 10.1038/s41598-021-04571-3] [Reference Citation Analysis]
|
| 27 |
Chandy E, Szmul A, Stavropoulou A, Jacob J, Veiga C, Landau D, Wilson J, Gulliford S, Fenwick JD, Hawkins MA, Hiley C, McClelland JR. Quantitative Analysis of Radiation-Associated Parenchymal Lung Change. Cancers (Basel) 2022;14:946. [PMID: 35205693 DOI: 10.3390/cancers14040946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Latrèche A, Bourbonne V, Lucia F. Unrecognized thoracic radiotherapy toxicity: A review of literature. Cancer/Radiothérapie 2022. [DOI: 10.1016/j.canrad.2021.10.008] [Reference Citation Analysis]
|
| 29 |
Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N. Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study). Ther Adv Med Oncol 2022;14:175883592211166. [DOI: 10.1177/17588359221116603] [Reference Citation Analysis]
|
| 30 |
Azghadi SF, Daly ME. Radiation Therapy-Induced Lung and Heart Toxicity. Medical Radiology 2022. [DOI: 10.1007/174_2022_336] [Reference Citation Analysis]
|
| 31 |
Zhao Q, Zhu J, Liu Y, Qin S, Zhou J. Preliminary evaluation of postoperative radiotherapy with small T-shaped field in thoracic esophageal squamous cell carcinoma. J Gastrointest Oncol 2021;12:2004-12. [PMID: 34790368 DOI: 10.21037/jgo-21-604] [Reference Citation Analysis]
|
| 32 |
Xu Y, Ma P, Hu Z, Tian Y, Men K, Wang S, Xu Y, Dai J. Non-coplanar volumetric modulated arc therapy for locoregional radiotherapy of left-sided breast cancer including internal mammary nodes. Radiol Oncol 2021;55:499-507. [PMID: 34821135 DOI: 10.2478/raon-2021-0045] [Reference Citation Analysis]
|
| 33 |
Hindocha S, Campbell D, Ahmed M, Giorgakoudi K, Sharma B, Yousaf N, Molyneaux P, Hunter B, Kalsi H, Cui W, Davidson M, Bhosle J, Minchom A, Locke I, McDonald F, O'Brien M, Popat S, Lee RW. Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications. Front Med (Lausanne) 2021;8:764563. [PMID: 34790682 DOI: 10.3389/fmed.2021.764563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Chen Y, Liu X, Huang Z, Zhao K, Wang Y, Ren F, Yu J, Meng X. Safety of thoracic radiotherapy after PD-(L)1 inhibitor treatment in patients with lung cancer. Cancer Med 2021;10:8518-29. [PMID: 34664788 DOI: 10.1002/cam4.4363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 35 |
Palma G, Monti S, Pacelli R, Liao Z, Deasy JO, Mohan R, Cella L. Radiation Pneumonitis in Thoracic Cancer Patients: Multi-Center Voxel-Based Analysis. Cancers (Basel) 2021;13:3553. [PMID: 34298767 DOI: 10.3390/cancers13143553] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 36 |
Bin L, Yuan T, Zhaohui S, Wenting R, Zhiqiang L, Peng H, Shuying Y, Lei D, Jianyang W, Jingbo W, Tao Z, Xiaotong L, Nan B, Jianrong D. A deep learning-based dual-omics prediction model for radiation pneumonitis. Med Phys 2021. [PMID: 34224595 DOI: 10.1002/mp.15079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 37 |
Yu JH, Zhao QY, Liu Y, Zhu XR, Yang ZR, Fu XL, Cai XW. The Plasma Levels and Polymorphisms of Vitronectin Predict Radiation Pneumonitis in Patients With Lung Cancer Receiving Thoracic Radiation Therapy. Int J Radiat Oncol Biol Phys 2021;110:757-65. [PMID: 33610390 DOI: 10.1016/j.ijrobp.2021.01.018] [Reference Citation Analysis]
|
| 38 |
Rahi MS, Parekh J, Pednekar P, Parmar G, Abraham S, Nasir S, Subramaniyam R, Jeyashanmugaraja GP, Gunasekaran K. Radiation-Induced Lung Injury-Current Perspectives and Management. Clin Pract 2021;11:410-29. [PMID: 34287252 DOI: 10.3390/clinpract11030056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 39 |
Mo H, Jazieh KA, Brinzevich D, Abraham J. A Review of Treatment-Induced Pulmonary Toxicity in Breast Cancer. Clin Breast Cancer 2021:S1526-8209(21)00142-7. [PMID: 34226162 DOI: 10.1016/j.clbc.2021.05.014] [Reference Citation Analysis]
|
| 40 |
Yin Q, Zhu B, Zhang J, Yu Y, Li P. A Likely Role for a Novel Cell Therapeutic Target of Transforming Growth Factor-β1 on Radiation Pneumonitis in Lung and Nasopharyngeal Cancer Patients. Cell Transplant 2020;29:963689720914245. [PMID: 32252552 DOI: 10.1177/0963689720914245] [Reference Citation Analysis]
|
| 41 |
Berg J, Ramberg C, Haugstvedt JOS, Bengtson MB, Gabrielsen AM, Brustugun OT, Halvorsen AR, Helland Å. Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers. Front Oncol 2021;11:674731. [PMID: 34109123 DOI: 10.3389/fonc.2021.674731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 42 |
Tang W, Li X, Yu H, Yin X, Zou B, Zhang T, Chen J, Sun X, Liu N, Yu J, Xie P. A novel nomogram containing acute radiation esophagitis predicting radiation pneumonitis in thoracic cancer receiving radiotherapy. BMC Cancer 2021;21:585. [PMID: 34022830 DOI: 10.1186/s12885-021-08264-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 43 |
Roy S, Salerno KE, Citrin DE. Biology of Radiation-Induced Lung Injury. Semin Radiat Oncol 2021;31:155-61. [PMID: 33610273 DOI: 10.1016/j.semradonc.2020.11.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 44 |
Xie J, Zhao M, Wang C, Yong Y, Gu Z, Zhao Y. Rational Design of Nanomaterials for Various Radiation-Induced Diseases Prevention and Treatment. Adv Healthc Mater 2021;10:e2001615. [PMID: 33506624 DOI: 10.1002/adhm.202001615] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 45 |
Jagoda P, Fleckenstein J, Sonnhoff M, Schneider G, Ruebe C, Buecker A, Stroeder J. Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC. Cancer Imaging 2021;21:15. [PMID: 33478592 DOI: 10.1186/s40644-021-00384-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 46 |
Yu JH, Wang CL, Liu Y, Wang JM, Lv CX, Liu J, Zhang Q, Fu XL, Cai XW. Study of the predictors for radiation pneumonitis in patient with non-small cell lung cancer received radiotherapy after pneumonectomy. Cancer Radiother 2021;25:323-9. [PMID: 33446419 DOI: 10.1016/j.canrad.2020.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 47 |
Lu S, Casarini I, Kato T, Cobo M, Özgüroğlu M, Hodge R, van der Gronde T, Saggese M, Ramalingam SS. Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non-small-cell Lung Cancer: LAURA Trial in Progress. Clin Lung Cancer 2021;22:371-5. [PMID: 33558193 DOI: 10.1016/j.cllc.2020.11.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 48 |
Koosha F, Pourbagheri-Sigaroodi A, Bakhshandeh M, Bashash D. Low-dose radiotherapy (LD-RT) for COVID-19-induced pneumopathy: a worth considering approach. Int J Radiat Biol 2021;97:302-12. [PMID: 33320755 DOI: 10.1080/09553002.2021.1864049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 49 |
Arroyo-Hernández M, Maldonado F, Lozano-Ruiz F, Muñoz-Montaño W, Nuñez-Baez M, Arrieta O. Radiation-induced lung injury: current evidence. BMC Pulm Med 2021;21:9. [PMID: 33407290 DOI: 10.1186/s12890-020-01376-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 50 |
Lutz CM, Knap MM, Hoffmann L, Møller DS, Hansen O, Brink C, Schytte T, Nyhus CH, McCulloch T, Borissova S, Alber M, Khalil AA. Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trial. Clin Transl Radiat Oncol 2021;27:8-14. [PMID: 33385069 DOI: 10.1016/j.ctro.2020.11.013] [Reference Citation Analysis]
|
| 51 |
Liao Y, Wang D, Gu Z. Research Progress of Nanomaterials for Radioprotection. Acta Chimica Sinica 2021;79:1438. [DOI: 10.6023/a21070319] [Reference Citation Analysis]
|
| 52 |
Bulman JC, Zurkiya O, Wu V, Wehrenberg-Klee E, Palmer E, Chow D, Brook A, Ganguli S. Repeat Evaluation of Lung Shunt Fraction is Unnecessary: A Retrospective Observational Study of Successive Lung Shunt Fractions from Variable Arterial Distributions in Patients Undergoing Radioembolization of Primary and Secondary Liver Tumors. J Vasc Interv Radiol 2021;32:412-8. [PMID: 33341340 DOI: 10.1016/j.jvir.2020.11.005] [Reference Citation Analysis]
|
| 53 |
Hoegen P, Lang C, Akbaba S, Häring P, Splinter M, Miltner A, Bachmann M, Stahl-Arnsberger C, Brechter T, El Shafie RA, Weykamp F, König L, Debus J, Hörner-Rieber J. Cone-Beam-CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Enables Quality Assurance and Superior Sparing of Healthy Lung. Front Oncol 2020;10:564857. [PMID: 33363005 DOI: 10.3389/fonc.2020.564857] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 54 |
Mishra S, Biswas S, Bhatnagar S. Palliative Care Delivery in Cancer Patients in the Era of Covid-19 Outbreak: Unique Needs, Barriers, and Tools for Solutions. Indian J Palliat Care 2020;26:S130-41. [PMID: 33088103 DOI: 10.4103/IJPC.IJPC_194_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 55 |
Harris WB, Zou W, Cheng C, Jain V, Teo BK, Dong L, Feigenberg SJ, Berman AT, Levin WP, Cengel KA, O'Reilly SE. Higher Dose Volumes May Be Better for Evaluating Radiation Pneumonitis in Lung Proton Therapy Patients Compared With Traditional Photon-Based Dose Constraints. Adv Radiat Oncol 2020;5:943-50. [PMID: 33083657 DOI: 10.1016/j.adro.2020.06.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 56 |
Yang X, Ni J, Li Y, Zou L, Guo T, Li Y, Chu L, Zhu Z. LncRNA-RP11 Modulates TGF-β1-Activated Radiation-Induced Lung Injury Through Downregulating microRNA-29a. Dose Response 2020;18:1559325820949071. [PMID: 33117089 DOI: 10.1177/1559325820949071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
Soh J, Sugimoto S, Namba K, Miura A, Shiotani T, Yamamoto H, Suzawa K, Shien K, Yamamoto H, Okazaki M, Katsui K, Yamane M, Kiura K, Kanazawa S, Toyooka S. Chronic Lung Injury After Trimodality Therapy for Locally Advanced Non-Small Cell Lung Cancer. Ann Thorac Surg 2021;112:279-88. [PMID: 33068542 DOI: 10.1016/j.athoracsur.2020.07.068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 58 |
Gritsenko A, Green JP, Brough D, Lopez-Castejon G. Mechanisms of NLRP3 priming in inflammaging and age related diseases. Cytokine Growth Factor Rev 2020;55:15-25. [PMID: 32883606 DOI: 10.1016/j.cytogfr.2020.08.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 59 |
Śliwińska-Mossoń M, Wadowska K, Trembecki Ł, Bil-Lula I. Markers Useful in Monitoring Radiation-Induced Lung Injury in Lung Cancer Patients: A Review. J Pers Med 2020;10:E72. [PMID: 32722546 DOI: 10.3390/jpm10030072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 60 |
Gharbavi M, Sharafi A, Ghanbarzadeh S. Mesenchymal Stem Cells: A New Generation of Therapeutic Agents as Vehicles in Gene Therapy. Curr Gene Ther 2020;20:269-84. [PMID: 32515309 DOI: 10.2174/1566523220666200607190339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 61 |
Liu CS, Schmezer P, Popanda O. Diacylglycerol Kinase Alpha in Radiation-Induced Fibrosis: Potential as a Predictive Marker or Therapeutic Target. Front Oncol 2020;10:737. [PMID: 32477950 DOI: 10.3389/fonc.2020.00737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 62 |
Salomaa S, Cardis E, Bouffler SD, Atkinson MJ, Hamada N. Low dose radiation therapy for COVID-19 pneumonia: is there any supportive evidence? International Journal of Radiation Biology 2020;96:1224-7. [DOI: 10.1080/09553002.2020.1762020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 63 |
O’reilly S, Jain V, Huang Q, Cheng C, Teo BK, Yin L, Zhang M, Diffenderfer E, Li T, Levin W, Xiao Y, Dong L, Feigenberg S, Berman AT, Zou W. Dose to Highly Functional Ventilation Zones Improves Prediction of Radiation Pneumonitis for Proton and Photon Lung Cancer Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 2020;107:79-87. [DOI: 10.1016/j.ijrobp.2020.01.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 64 |
Schlaak RA, SenthilKumar G, Boerma M, Bergom C. Advances in Preclinical Research Models of Radiation-Induced Cardiac Toxicity. Cancers (Basel) 2020;12:E415. [PMID: 32053873 DOI: 10.3390/cancers12020415] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 65 |
Shukla NA, Hanna NH. Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation. Lung Cancer Manag 2020;9:LMT23. [PMID: 32256709 DOI: 10.2217/lmt-2020-0001] [Reference Citation Analysis]
|
| 66 |
Tang Y, Yang L, Qin W, Yi MX, Liu B, Yuan X. Impact of genetic variant of HIPK2 on the risk of severe radiation pneumonitis in lung cancer patients treated with radiation therapy. Radiat Oncol 2020;15:9. [PMID: 31915028 DOI: 10.1186/s13014-019-1456-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 67 |
De Ruysscher D, Faivre-finn C, Nackaerts K, Jordan K, Arends J, Douillard J, Ricardi U, Peters S. Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer. Annals of Oncology 2020;31:41-9. [DOI: 10.1016/j.annonc.2019.10.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 68 |
Zoto Mustafayev T, Atalar B. Toxicity Management for Thorax Tumors in Radiation Oncology. Prevention and Management of Acute and Late Toxicities in Radiation Oncology 2020. [DOI: 10.1007/978-3-030-37798-4_4] [Reference Citation Analysis]
|
| 69 |
Zeng Q, Tang C, Deng L, Li S, Liu J, Wang S, Shan H. Differential Diagnosis of COVID-19 Pneumonia in Cancer Patients Received Radiotherapy. Int J Med Sci 2020;17:2561-9. [PMID: 33029098 DOI: 10.7150/ijms.46133] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 70 |
Wang L, Liang S, Li C, Sun X, Pang L, Meng X, Yu J. A Novel Nomogram and Risk Classification System Predicting Radiation Pneumonitis in Patients With Esophageal Cancer Receiving Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 2019;105:1074-85. [DOI: 10.1016/j.ijrobp.2019.08.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 71 |
Lin WC, Chang CL, Hsu HL, Yuan KS, Wu ATH, Wu SY. Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2019;11:E1529. [PMID: 31658709 DOI: 10.3390/cancers11101529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 72 |
Tang Y, Yang L, Qin W, Yi M, Liu B, Yuan X. Validation study of the association between genetic variant of IL4 and severe radiation pneumonitis in lung cancer patients treated with radiation therapy. Radiother Oncol 2019;141:86-94. [PMID: 31540745 DOI: 10.1016/j.radonc.2019.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 73 |
Oncology and palliative care. Oxford Handbook of Palliative Care 2019. [DOI: 10.1093/med/9780198745655.003.0006] [Reference Citation Analysis]
|
| 74 |
Kong M, Lim YJ, Kim Y, Chung MJ, Min S, Shin DO, Chung W. Diabetes mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lung cancer. Cancer Manag Res 2019;11:7103-10. [PMID: 31440097 DOI: 10.2147/CMAR.S210095] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 75 |
Lu L, Sun C, Su Q, Wang Y, Li J, Guo Z, Chen L, Zhang H. Radiation-induced lung injury: latest molecular developments, therapeutic approaches, and clinical guidance. Clin Exp Med 2019;19:417-26. [PMID: 31313081 DOI: 10.1007/s10238-019-00571-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 76 |
Sakaguchi T, Ito K, Furuhashi K, Nakamura Y, Suzuki Y, Nishii Y, Taguchi O, Hataji O. Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria. Respir Investig. 2019;57:466-471. [PMID: 31104989 DOI: 10.1016/j.resinv.2019.03.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 77 |
Tang X, Li Y, Tian X, Zhou X, Wang Y, Huang M, Ren L, Zhou L, Xue J, Ding Z, Zhu J, Xu Y, Peng F, Wang J, Lu Y, Gong Y. Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: Development and internal validation of a nomogram based on the clinical and dose–volume histogram parameters. Radiotherapy and Oncology 2019;132:197-203. [DOI: 10.1016/j.radonc.2018.10.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 78 |
De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM, Hegi-Johnson F. Radiotherapy toxicity. Nat Rev Dis Primers 2019;5:13. [PMID: 30792503 DOI: 10.1038/s41572-019-0064-5] [Cited by in Crossref: 280] [Cited by in F6Publishing: 287] [Article Influence: 70.0] [Reference Citation Analysis]
|
| 79 |
Schwarz M, Kocher F, Niedersuess-Beke D, Rudzki J, Hochmair M, Widmann G, Hilbe W, Pircher A. Immunosuppression for Immune Checkpoint-related Toxicity Can Cause Pneumocystis Jirovecii Pneumonia (PJP) in Non-small-cell Lung Cancer (NSCLC): A Report of 2 Cases. Clin Lung Cancer 2019;20:e247-50. [PMID: 30635258 DOI: 10.1016/j.cllc.2018.12.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
|
